Session Title: Achieving Better Control of Severe Asthma: New Understandings in Asthma Pathophysiology and Targeted Therapies

Faculty Presenter: Paul A. Greenberger, MD, Professor of Medicine, Division of Allergy and Immunology, Northwestern Feinberg School of Medicine (Chicago, Illinois)

Session Objectives:

  • Describe a thorough assessment of asthma severity and control in day-to-day practice
  • Explain how mechanisms of action in new/emerging Type 2 inflammation-directed treatments address the underlying immunology of asthma
  • Select appropriate Type 2 inflammation-targeted therapies on the basis of safety and efficacy data, and phenotype

Registration for this session has closed. To view the online training, click here.

Accreditation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The France Foundation and the Respiratory Health Association. The France Foundation is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation: The France Foundation designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ and 1 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Respiratory Health Association is an approved continuing education sponsor recognized by the State of Illinois Department of Financial and Professional Regulation. Respiratory Health Association is offering 1.0 hour of continuing education for Respiratory Care Practitioners (RCPs).

This educational activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.

For questions about future educational sessions, contact Amy O’Rourke at aorourke@lungchicago.org or 312-628-0217.